D-0337-2018 Class I Terminated
FDA drug recall D-0337-2018 was initiated by AuroMedics Pharma LLC on Dec 20, 2017 and is designated Class I. Reason for recall: Presence of Particulate Matter; white particulate matter identified as mold was found in one bag The recall status is terminated (terminated Jun 24, 2019). Affected quantity: 9,050 bags.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 14, 2018
- Initiation Date
- Dec 20, 2017
- Termination Date
- Jun 24, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 9,050 bags
Product description
Linezolid Injection 600 mg/300 mL (2 mg/mL), 300 mL Single-use, ready-to-use flexible plastic infusion bags in a foil laminate overwrap, Rx only, Mfd in India for: AuroMedics Pharma LLC, Dayton, NJ --- NDC 55150-242-51
Reason for recall
Presence of Particulate Matter; white particulate matter identified as mold was found in one bag
Distribution pattern
Product was distributed throughout United States.
Code information
Lot # CLZ160007, Exp August 2018
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0337-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026